Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A & Combine Study Research Group. Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. Journal of the American Medical Association 295(17):2003-2017, 2006.

Anton RF & Youngblood M. Factors affecting %CDT status at entry into a multisite clinical treatment trial: Experience from the COMBINE study. Alcoholism: Clinical & Experimental Research 30(11):1878-1883, 2006.

Brady KT, Back SE, Waldrop AE, McRae AL, Anton RF, Upadhyaya HP, Saladin ME & Randall PK. Cold pressor task reactivity: Predictors of alcohol use among alcohol-dependent individuals with and without comorbid posttraumatic stress disorder. Alcoholism: Clinical & Experimental Research 30(6):938-946, 2006.

Brady KT, Waldrop AE, McRae AL, Back SE, Saladin ME, Upadhyaya HP, Anton RF & Randall PK. The impact of alcohol dependence and posttraumatic stress disorder on cold pressor task response. Journal of Studies on Alcohol 67(5):700-706, 2006.

Miller PM, Spies C, Neumann T, Javors MA, Hoyumpa AM, Roache J, Webb A, Kashi M, Sharkey FE, Anton RF, Egan BM, Basile J, Nguyen S, Fleming MF & Dillie KS. Alcohol biomarker screening in medical and surgical settings. Alcoholism: Clinical and Experimental Research 30(2):185-193, 2006.

Work Group on Substance Use Disorders (Anton RF) & American Psychiatric Association Steering Committee on Practice Guidelines. Treatment of patients with substance use disorders, Second Edition. American Psychiatric Association. American Journal of Psychiatry 163(8 Suppl):5-82, 2006.

Baros AM, Latham PK, Moak DH, Voronin K & Anton RF. What role does measuring medication compliance play in evaluating the efficacy of naltrexone? Alcoholism: Clinical & Experimental Research 31(4):596-603, 2007.

Cluver JS, Miller PM & Anton RF. Case studies of the utility of serum carbohydrate-deficient transferrin (%CDT) in the clinical management of alcoholics. Journal of Addiction Medicine 1(1):44-47, 2007.

Jeppsson J-O, Arndt T, Schellenberg F, Wielders JPM, Anton RF, Whitfield JB, Helander A & International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Standardization of Carbohydrate-Deficient Transferin. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clinical Chemistry & Laboratory Medicine 45(4):558-562, 2007.

Myrick H, Anton RF, Voronin K, Wang W & Henderson S. A double blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. Alcoholism: Clinical & Experimental Research 31(2):221-227, 2007.

Work Group on Substance Use Disorders (Anton RF). Practice guideline for the treatment of patients with substance use disorders. Supplement to American Journal of Psychiatry 164(4):A5-124, 2007.

Wright TM, Baros AM & Anton RF. Pharmacotherapies for the Treatment of Alcohol Dependence: Current and on the Horizon In Translation of Addictions Science into Practice: Update and Future Directions, Miller PM, Kavanagh D (Eds). Elsevier-Pergamon, New York, NY, 2007.

Wright TM, Myrick H, Malcolm R, Randall P, Boyle E, Henderson S & Anton R. Impact of lifetime alcohol quit attempts and medicated detoxifications on time to relapse during an index alcohol detoxification. Journal of Addiction Medicine 1(1):15-20, 2007.